iiinova — where your digital self keeps evolving

John Kim @jskim8223.bsky.social · 09/06/2026

Our @atsblueeditor.bsky.social paper is online. We generated an age-adjusted nomogram for WGS-telomere length from #MESA & #COPDGene and applied it to IPF cases. doi.org/10.1093/ajrc...

040

John Kim @jskim8223.bsky.social · 22/05/2026

Our paper is online @atsblueeditor.bsky.social examining gut microbiome features in IPF. We identified gut microbial signatures that correspond to lung function, survival, and interact with long-term antibiotic exposure. academic.oup.com/ajrccm/artic...

141

Reposted by John Kim

KaminskiMed @kaminskimed.bsky.social · 01/12/2025

Finally in Print! The Official ATS Research Statement on Racial, Ethnic, Sex & Gender Equity for Inclusive Interstitial Lung Disease Research. 👏🏼 Drs Assayag, Adegonsoye, Cottin, Mageto & @atsblueeditor.bsky.social & @atscommunity.bsky.social #CurePF4All www.atsjournals.org/doi/10.1164/...

084

Reposted by John Kim

Kerri Johannson MD MPH @kerrijohannson.bsky.social · 02/11/2025

Okay #MedSky #AcademicSky 📚 What is the optimal number of reviewers for a run-of-the-mill manuscript @ reg journal (i.e. not Science/NEJM) Some journals invite 4-5 as default 🤯 I think 2 is sufficient, max 3 if controversy More reviewers ➡️ less AE provides input And SO many hours of free labour 💪

media.tenor.com

a man says " it 's too much " in front of a window

Alt: Schitt’s creek David says " it 's too much " in front of a window

2103

John Kim @jskim8223.bsky.social · 08/10/2025

Thrilled our paper made it to the @atsblueeditor.bsky.social ILD issue this month. Look forward to building on this work and welcome collaboration with anyone interested in subclinical pulmonary fibrosis. I think a future research area is mapping the blood-lung proteome in this context.

000

Reposted by John Kim

ATS Blue Journal @atsblueeditor.bsky.social · 03/10/2025

The Blue Journal thanks Riley Hannan, PhD, for his contribution to the October issue Associations of High Attenuation Area-Related Proteomic Biomarkers with Fibrotic or Subpleural Interstitial Lung Abnormalities @jskim8223.bsky.social www.atsjournals.org/doi/full/10....

011

Reposted by John Kim

ATS Blue Journal @atsblueeditor.bsky.social · 23/07/2025

Approach to the Evaluation and Management of Interstitial Lung Abnormalities: An Official American Thoracic Society Clinical Statement @atscommunity.bsky.social #medsky 🔓 Open Access 🔗 tinyurl.com/4vjm9zdw

054

Reposted by John Kim

The Lancet Respiratory Medicine @lancetrespirmed.bsky.social · 29/04/2025

🧬 Rare variants and survival of patients with idiopathic pulmonary fibrosis: analysis of a multicentre, observational cohort study with independent validation 📈 Non-additive effects were seen between qualifying variants and common risk variants in #IPF survival 🔗 www.thelancet.com/journals/lan...

Image of DNA double helix and fingerprint representing genetic fingerprint
Copyright © 2025 KTSDesign/Science Photo Library

121

Reposted by John Kim

Aitana Alonso @aitanaag90.bsky.social · 29/04/2025

Delighted to share our new study evaluating the association of rare variants in telomere and non-telomere monogenic adult-onset Pulmonary Fibrosis genes and IPF patient survival where we also intersected their effects with #PRS of IPF.

144

John Kim @jskim8223.bsky.social · 12/04/2025

Had the privilege giving a talk about early ILD detection and sharing some of the research we are doing at #KATRD annual meeting in #Gyeongju. Thank you for the opportunity and meeting so many wonderful pulmonologists.

020

Reposted by John Kim

Nick Banovich @nebanovich.bsky.social · 04/02/2025

Excited to post my first #skySplain about our recent work published yesterday in Nature Genetics! www.nature.com/articles/s41.... One of the first authors of this study - Annika Vannan – actually wrote this breakdown, but she's not yet over here on bluesky and asked me to post!

nature.com

Spatial transcriptomics identifies molecular niche dysregulation associated with distal lung remodeling in pulmonary fibrosis - Nature Genetics

Xenium spatial transcriptomic profiling of pulmonary fibrosis characterizes cell composition dynamics and histopathological features associated with the disease.

35523

Reposted by John Kim

Annals of the ATS @annalsats.bsky.social · 14/01/2025

Genomic and Serological Rheumatoid Arthritis Biomarkers, MUC5B Promoter Variant, and Interstitial Lung Abnormalities @atscommunity.bsky.social #medsky 🔗 tinyurl.com/mr4cke25

062

Reposted by John Kim

Kerri Johannson MD MPH @kerrijohannson.bsky.social · 04/01/2025

🌟 Impact of Environmental Exposures on the Development and Progression of Fibrotic Interstitial Lung Disease 🌟 Just out in @atsblueeditor.bsky.social 🫁 www.atsjournals.org/doi/abs/10.1... State of the Art: -Epidemiology -Mechanisms of Injury -Implications - clinical & policy -Future directions

Screenshot of the article title and authors

1216

Reposted by John Kim

Kerri Johannson MD MPH @kerrijohannson.bsky.social · 21/12/2024

Now can we use CA-125 as a theragnostic biomarker of treatment response in patients with IPF? Why wouldn't we? @ipfdoc.bsky.social @kaminskimed.bsky.social #CurePF #CureIPF @ats-clinicalprobs.bsky.social @tkulkarni.bsky.social @jskim8223.bsky.social pmc.ncbi.nlm.nih.gov/articles/pmi...

screenshot of study title. Effects of nintedanib on biomarkers in IPF in ERJ Open.

2106

Reposted by John Kim

ATS Blue Journal @atsblueeditor.bsky.social · 18/12/2024

The Blue Journal thanks Catherine L. Debban, PhD, for her contribution to the December 15 issue Dysanapsis Genetic Risk Predicts Lung Function Across the Lifespan www.atsjournals.org/doi/full/10....

021

Reposted by John Kim

Jack Iwashyna @iwashyna.bsky.social · 06/12/2024

last night, Hallie Prescott had her NEJM review on sepsis released: www.nejm.org/doi/full/10.... Today I had the pleasure of giving some remarks on her installation as the Toews Family Legacy Professor at the University of Michigan

nejm.org

Sepsis and Septic Shock | NEJM

Sepsis is a life-threatening, heterogeneous disorder involving a dysregulated immune response to infection. Research to identify subtypes and targeted therapies for host dysregulation is ongoing.

36214

Reposted by John Kim

Gísli @ipfdoc.bsky.social · 05/12/2024

Using Mendelian Randomisation to identify causal associations in #IPF a 🧵

182

Reposted by John Kim

Kerri Johannson MD MPH @kerrijohannson.bsky.social · 14/11/2024

For the new BlueSky members who have left #ILDTwitter I’ve updated this starter-pack to help you find key ILD and ILD-adjacent community members here. Pls comment if I’ve missed you and I’ll add you 🫁😊 #CurePF #CureIPF #ILD go.bsky.app/8u4KcNo

5138